Have a personal or library account? Click to login
Influence Of The Number Of Platelets And Hemoglobin Concentrations In Predicting The Development Of Proteinuria Induced By The Administration Of Bevacizumab Cover

Influence Of The Number Of Platelets And Hemoglobin Concentrations In Predicting The Development Of Proteinuria Induced By The Administration Of Bevacizumab

EABR. Experimental and Applied Biomedical Research
Volume 16 (2015): Issue 2 (June 2015)
By: Vera Dabanovic  
Open Access
|Jun 2015

References

  1. 1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disesase. Nature Medicine 1995;1:27-31.10.1038/nm0195-277584949
    Search in Google Scholar
  2. 2. Jain RK, “Molecular Regulation of Vessel Maturation,” Nature Medicine 2003; 9:685-693.10.1038/nm0603-68512778167
    Search in Google Scholar
  3. 3. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Department of Molecular Oncology. 2000; 55:15-35.
    Search in Google Scholar
  4. 4. Dunst, J., Pigorsch, S., Hansgen, G., Hintner, I., Lautenschlager, C., Becker, A. Low hemoglobin is associated with increased levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? Strahlenther Onkologie. 1999; 175: 93-96.10.1007/BF0274234010093609
    Search in Google Scholar
  5. 5. Gerber H, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. Journal of Biological Chemistry 1997; 272: 23659-67.10.1074/jbc.272.38.236599295307
    Search in Google Scholar
  6. 6. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Research 1995; 55(23):5687-92.
    Search in Google Scholar
  7. 7. Battinelli EM, Markens BA, Italiano JE. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiological and pathological angiogenesis. Blood. 2011;118(5):1359-69.10.1182/blood-2011-02-334524315250021680800
    Search in Google Scholar
  8. 8. Carmeliet P., Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407(6801): 249-57.10.1038/3502522011001068
    Search in Google Scholar
  9. 9. Poon RT-P, Fan S-T, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. Journal of Clinical Oncology 2001; 19(4): 1207–25.10.1200/JCO.2001.19.4.120711181687
    Search in Google Scholar
  10. 10. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Medicine 2001; 7(9): 987-9.10.1038/nm0901-98711533692
    Search in Google Scholar
  11. 11. FDA Approval for Bevacizumab. National Cancer Institute. (Accessed in May 2013 at http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab)
    Search in Google Scholar
  12. 12. SPC Avastin (Accessed in Sep 2012 at http://www.medicines.org.uk/emc/medicine/15748)
    Search in Google Scholar
  13. 13. Abbate M, Zoja C, Remuzzi G. How Does Proteinuria Cause Progresive Renal Damage? Journal of the American Society of Nephrology 2006; 17(11): 2974-84.
    Search in Google Scholar
  14. 14. Loon NR. Diabetic Kidney Disease: Preventing Dialysis and Transplantation. Clinical Diabetes 2003; 21(2): 55-62.10.2337/diaclin.21.2.55
    Search in Google Scholar
  15. 15. Clinical Research Protocols. National Institutes of Health. (Accessed in June 2012 at http://www.niehs.nih.gov/about/od/ethics/protocols/)
    Search in Google Scholar
  16. 16. Harshman LC, Kuo CJ, Wong BY, Vogelzang NJ, Srinivas S. Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma. Cancer Investigation. 2009 Oct; 27(8):851-6.10.1080/0735790090274452819603304
    Search in Google Scholar
  17. 17. Mutlu H, Berk V, Karaca H, Erden A, Aslan T, Akca Z. Treatment Regimen With Bevacizumab Decreases Mean Platelet Volume in Patients With Metastatic Colon Cancer. Clinical and Applied Thrombosis/Hemostasis 2012; 18 (5): 546-548.10.1177/107602961143095822203035
    Search in Google Scholar
  18. 18. DiLeo A, Messa C, Russo F, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa: preliminary results. Dig Dis Sci. 1994;39:2038-2042.10.1007/BF020881448082515
    Search in Google Scholar
  19. 19. Heon Seo K, Lee HS, Jung B, et al. Estrogen Enhances Angiogenesis through a Pathway Involving Platelet-Activating Factor-Mediated Nuclear Factor-KB Activation. Cancer Research 64, 2004; 6482-6488.10.1158/0008-5472.CAN-03-277415374958
    Search in Google Scholar
  20. 20. Witte D, Chirala M, Younes A, Li Y and Younes M: Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Human Pathology 2001;32: 940-944.10.1053/hupa.2001.2711711567223
    Search in Google Scholar
  21. 21. Hendifar A, et al. Gender Disparities in Metastatic Colorectal Cancer Survival. Clinical Cancer Research 2009; (15): 6391.10.1158/1078-0432.CCR-09-0877277976819789331
    Search in Google Scholar
  22. 22. Schmetzer O, Flörcken A. Sex differences in the drug therapy for oncologic diseases. Handbook of Experimental Pharmacology. 2012;(214):411-42.10.1007/978-3-642-30726-3_1923027461
    Search in Google Scholar
  23. 23. Wakelee HA, Dahlberg SE, Brahmer JR, et al.: Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab. Lung Cancer 76, 2012;(3): 410-5.10.1016/j.lungcan.2011.12.006346063922266041
    Search in Google Scholar
  24. 24. Cassidy J, Saltz LB, Giantonio BJ, Kabbinavar FF, Hurwitz HI, Rohr UP. Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. Journal of Cancer Research and Clinical Oncology 2010; 136(5): 737-743.10.1007/s00432-009-0712-3284175519904559
    Search in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0019 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 143 - 150
Submitted on: Dec 16, 2013
Accepted on: Jan 10, 2014
Published on: Jun 27, 2015
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
angiogenesis,
bevacizumab,
VEGF,
platelets,
haemoglobin
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 Vera Dabanovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 16 (2015): Issue 2 (June 2015)Next article